Nominee Committee
The Nomination Committee prepares and presents proposals for resolutions to the Annual General Meeting (AGM).
At the AGM on 29 April 2025, the Chairman of the Board was tasked with contacting the largest shareholders by voting power as of 31 December 2024 and asking them to appoint members to a Nomination Committee together with the CEO, Karl Kristian Bergman Jensen. The Nomination Committee consists of four members.
Given New Nordic’s ownership structure, Karl Kristian Bergman Jensen, in his capacity as representative of the principal shareholder, Vaccinium Holding ApS, is the natural choice to chair New Nordic’s Nomination Committee. This deviates from section 2.4 of the Swedish Corporate Governance Code.
It is the responsibility of the Nomination Committee, ahead of the General Meeting, to determine whether it finds it necessary to propose changes to the relevant principles to the AGM.
The main task of the Nomination Committee is to propose board members, the Chair of the Board, and auditors as well as remuneration for these, in such a way that the AGM is able to make well-informed decisions. The Nomination Committee has access to the evaluation that the Board conducts of its own work, as well as information about the company’s operations and strategic direction.
Proposals to the General Meeting
The proposals of the Nomination Committee are published in connection with the notice to the AGM and are also made available on the company’s website together with a description of its work. The Nomination Committee’s mandate period extends until a new Nomination Committee has been appointed. No remuneration is paid for work on the Nomination Committee.
New Nordic’s Nomination Committee for the 2026 Annual General Meeting
The Annual General Meeting of New Nordic Healthbrands AB will be held on 29 April 2026.
The Nomination Committee for the 2026 AGM has now been appointed by the largest shareholders in New Nordic Healthbrands AB (publ) and consists of the following members:
•Karl Kristian Bergman Jensen, Vaccinium Holding ApS, Chair of the Nomination Committee
•Marinus Blåbjerg Sørensen, Fjord Capital ApS
•Niclas Johansson
•Alexandre Pergament, Vitalco S.A.
The shareholders who appointed members to the Nomination Committee together represent approximately 80 percent of the total voting rights in New Nordic.
Shareholders wishing to submit proposals to the Nomination Committee may do so via email to kk@newnordic.comor by post to:
The Nominee Committee
New Nordic Healthbrands AB
Hyllie Boulevard 34
215 32 Malmö
Proposals must be received by the Nomination Committee no later than 2 January 2026.
FOR MORE INFORMATION, PLEASE CONTACT:
Karl Kristian Bergman Jensen, Chair of the Nomination Committee
Link to New Nordic’s investor relations website: https://newnordicinvestor.com
Phone: +46 40-239520
Press release:
New Nordic pressmeddelande – Valberedning 14-11-2025
